Therapies targeting AhRs and IDO1 could combat COVID-19, paper says
Researchers have hypothesised that treatments targeting the downregulation of AhRs and IDO1 genes could reduce severity of COVID-19 infection.
List view / Grid view
Researchers have hypothesised that treatments targeting the downregulation of AhRs and IDO1 genes could reduce severity of COVID-19 infection.
A recent study has revealed new findings about nerve cell development that could help to facilitate future treatment options for spinal cord injuries.
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
Researchers have revealed the molecular mechanism behind a rare mutation has been associated with numerous neurodegenerative diseases...